In June 2006, the American Medical Association catapulted its salt policy into the headlines. In a bold step the association's membership voted to implement several strategies to reduce salt intake. The members voted (a) to urge the Food and Drug Administration (FDA) to revoke the “generally recognized as safe” (GRAS) status of salt and develop regulatory measures limiting the amount of salt in processed and restaurant foods; (b) to establish quantifiable milestones, specifically a 50% reduction over the next decade, in the salt content of processed foods, fastfood products, and restaurant meals; (c) to join in partnership with organisations to educate consumers about the benefits of long term salt reduction; and (d) to work with the FDA to improve food labelling and develop warning labels for foods high in salt. The association's decision to advocate salt reduction follows a recent series of reports in the United States recommending sharp reductions in salt consumption, largely because of its adverse effects on blood pressure.1-5
The response from industry was swift and predictable. Leading the charge against the proposal is the Salt Institute, an international trade organisation of salt producers. In a news release, the Salt Institute claimed that “the American Medical Association has misread the science, confusing blood pressure effects with health outcomes.” The Salt Institute, now allied with the US Chamber of Commerce, argues that policy making should rely only on evidence from clinical trials that use clinical outcomes such as stroke and mortality rather than intermediary outcomes such as blood pressure. However, blood pressure is an important, aetiologically relevant risk factor for cardiovascular and renal diseases and is widely accepted as a valid marker for policy making.6 In addition, a large scale, long term, lifestyle modification trial with clinical outcomes is unrealistic. It would not be worth the considerable time and expense because of the overwhelming evidence for salt's adverse effects on blood pressure.7
Reducing salt intake is similar to achieving other lifestyle modifications in that a substantial public health approach will be required in addition to changes in individual behaviour. The need for a public health approach is even greater with salt reduction than other lifestyle modifications. In contrast to cigarette smoking, where use is evident to the consumer, the salt content of our diets is not readily apparent: over 75% of consumed salt comes from processed foods.8
Hence, any meaningful strategy to reduce salt intake must involve the efforts of food manufacturers and restaurants, either voluntarily (by persuasion) or involuntarily (by regulation). The latter may be required, given the initial response of commercial bodies to the American Medical Association's proposal. The need for public health approaches is also apparent, given the global burden of hypertension (estimated worldwide prevalence of 972 million persons in 20009) and the limited success of lifestyle interventions designed to reduce individuals' salt intake. Such interventions have been notoriously difficult to implement, especially in the setting of a food supply containing “hidden” salt.
In clinical trials, intensive interventions that focused just on salt reduction have shifted mean intake to about 100 mmol (2.3 g) of sodium (equivalent to 5.8 g of salt) a day.10-12 When efforts to reduce salt intake were combined with weight loss11 or as part of a comprehensive lifestyle intervention programme,13 salt reduction was more modest, probably because of the complexity of making multiple lifestyle changes and potential tradeoffs when there are several lifestyle goals.
The proposal by the American Medical Association may represent a turning point in public health efforts that have so far been largely ineffective in the US. The actions of doctors and their leadership carry enormous weight, as they did for tobacco control efforts. It is reasonable to conceive that physicians' actions have been an integral, if not essential, component of tobacco control efforts in the US, given their influence on individual patients, their communities, and healthcare policy.
Advice to reduce salt intake has been issued for about 30 years, despite persistent and highly aggressive attempts by commercial interests to weaken recommendations. With publication of the US Dietary Guidelines report4 and a subsequent “harmonisation” process, salt recommendations are now uniform and accepted by all branches of the federal government. Recommendations are also more stringent—the currently recommended upper limit of sodium intake is 100 mmol a day in the general population and 65 mmol a day in people who are especially sensitive to the adverse effects of sodium (African-Americans, middle aged and older individuals, and people with hypertension, diabetes, or chronic kidney disease).4
The critical issue in the US, as in most other countries, is developing a comprehensive strategy to achieve meaningful, population-wide reduction in salt intake. In this setting, the association's proposal is a logical and coherent framework for accomplishing this vitally important public health objective.
Competing interests: None declared.
References
- 1.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42: 1206-52. [DOI] [PubMed] [Google Scholar]
- 2.Havas S, Roccella EJ, Lenfant C. Reducing the public health burden from elevated blood pressure levels in the United States by lowering intake of dietary sodium. Am J Public Health 2004;94(1): 19-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. Washington, DC: National Academies Press, 2005.
- 4.2005 Dietary Guidelines Advisory Committee Report. www.health.gov/dietaryguidelines/dga2005/report/ (accessed 11 Sep 2006).
- 5.Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM, et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006;47: 296-308. [DOI] [PubMed] [Google Scholar]
- 6.He J, Kearny PM, and Muntner P. Blood pressure and risk of vascular disease. In: Whelton PK, He J, Louis GT, eds. Lifestyle modification for the prevention and treatment of hypertension. New York: Marcel Dekker, 2003: 23-51.
- 7.He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004;(1):CD004937. [DOI] [PubMed]
- 8.Mattes RD, Donnelly D. Relative contributions of dietary sodium sources. J Am Coll Nutr 1991;10: 383-93. [DOI] [PubMed] [Google Scholar]
- 9.Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365: 217-23. [DOI] [PubMed] [Google Scholar]
- 10.The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the trials of hypertension prevention, phase I. JAMA 1992;267: 1213-20. [DOI] [PubMed] [Google Scholar]
- 11.Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The trials of hypertension prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med 1997;157: 657-67. [PubMed] [Google Scholar]
- 12.Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998;279: 839-46. [DOI] [PubMed] [Google Scholar]
- 13.Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006;144: 485-95. [DOI] [PubMed] [Google Scholar]